Patrick Vanek Email & Phone Number

Naples, Florida, Us

Naples, Florida, Us

Naples, Florida, Us

★ Advises corporate leadership on design, engineering, technical, logistics and manufacturing issues.★ Manages global technology transfers of the medical devices of acquired companies.★ Responsible for the integration of the Angel and ActivAT systems to Arthrex following the company’s acquisition of a licensing agreement governing manufacturing.ABOUT ARTHREX INC.Arthrex is a global medical device company and leader in new product development and medical education in orthopaedics. With a corporate mission of helping surgeons treat their patients better, Arthrex has pioneered the field of arthroscopy and developed more than 7,500 innovative products and surgical procedures to advance minimally invasive orthopaedics worldwide.

Houston, Tx, Us

★ Co-pioneered the launch and continued management of this early-stage producer of biodynamic therapies, with authority over design, engineering, technical and production operations. Transitioned to Operations Consultant in the latter quarter of 2015 (August -December 2015: as PATRx Consulting, LLC).★ Managed the company to growth, expanding employee headcount and driving annual revenue to a peak of $20MM.★ Optimized inventory across multiple product lines, stabilized the supply chain, eliminated backorders, and nearly eliminated order errors, capturing improved customer satisfaction.★ Reduced the cost of critical components by up to 68% through effective negotiations with vendors; secured approval from the FDA to import a crucial reagent.ABOUT NUO THERAPEUTICSNuo Therapeutics, Inc. (formerly Cytomedix, Inc.) is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing.

Princeton, Nj, Us

★ Advanced through a series of management roles, starting as Manager of Technical Services and Process Development and culminating in Vice President of Technical Operations in 2008.★ Oversaw technical development initiatives supporting the production and commercialization of clinical therapies, pharmaceuticals, and medical devices; responsible for Investigational Materials, Quality Control & Analytical Services, Quality Assurance, Technical Services & Process Development, and Inventory Control & Logistics.★ Directed a team of 33 professionals distributed across multiple departments.★ Partnered with companies with the talent and technologies aligned with the needs of Otsuka America Pharmaceuticals.★ Created expertise within US operations that directly influenced corporate formulation development and manufacturing process development organizations in Japan.★ Directed the invention of fluid methods and applications that achieved US and international patent protection and have been commercialized in Japan.★ Launched five branded products and one generic product that skyrocketed company growth from $12MM in 1998 to over $4B today.★ Achieved distinction as the sole recipient of the Otsuka Core Value Award in 2008 for demonstrating behavior consistent with the company’s core value of individual respect.ABOUT OTSUKA AMERICA PHARMACEUTICALOtsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes Otsuka-discovered and in-licensed products in North America.

Chesterfield, Mo, Us

Director of the technical department supporting the early-stage pharmaceutical product development through commercial-scale manufacturing. Responsible for technical transfer of immediate-release and sustained-release solid oral dosage forms (Rx and OTC products) into and out of the facility for the corporate branded & generic divisions and contract-manufacturing customers. Provided the technical expertise/perspective to ensure the appropriate tests/verifications were conducted given the formulation’s and/or process’ characteristics. Key technical signatory for all validation-related activities (approval of protocols, etc.).Projects & Accomplishments: • Increased productivity of higher volume products through process/equipment optimization resulting in 33-70% increases in process (and/or laboratory/ analytical) efficiency. • Simplified the sampling/testing designs of scale-up (e.g., pre-validation) batches, resulting in the extraction of more data from fewer samples and decreasing overall analytical workload by as much as 50-75%. • Improved Coating Department process efficiencies by ~33% by identifying sources of process/ equipment design failure and modifying coating techniques.

Tel-Aviv, Il

Formed and directed a nine (9) member Process Development group responsible for the process development and technical services functions (for solid, liquid, topical and parenteral dosage forms) including scale-up and transfer of new products into the manufacturing facility, equipment qualification, and process/formulation troubleshooting and improvement.